In 2015, Devikala et al. reported that the expression of IL-13 was positively correlated with human prostatic tumors, and that tumors obtained from TRAMP+Il13−/− mice were smaller than those obtained from TRAMP+Il13+/− or TRAMP+Il13+/+ mice [41]. This evidence concerns the gene IL13 and prostate neoplasm.